{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:43:57Z","timestamp":1790869437664,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.abd.2020.05.003","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T17:08:37Z","timestamp":1599844117000},"page":"731-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Azathioprine: its uses in dermatology"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-7956","authenticated-orcid":false,"given":"Sonia","family":"Chavez-Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6299-1821","authenticated-orcid":false,"given":"Maira","family":"Herz-Ruelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4783-3793","authenticated-orcid":false,"given":"Alejandra","family":"Villarreal-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0213-0031","authenticated-orcid":false,"given":"Jorge","family":"Ocampo-Candiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6638-9851","authenticated-orcid":false,"given":"Rubicela","family":"Garza-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4212-0185","authenticated-orcid":false,"given":"Minerva","family":"Gomez-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2020.05.003_bib0005","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archdermatol.2011.79","article-title":"Off-label use of azathioprine in dermatology: a systematic review","volume":"147","author":"Schram","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0015","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-2133.2004.06323.x","article-title":"Guidelines for prescribing azathioprine in dermatology","volume":"151","author":"Anstey","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2005.07.059","article-title":"Azathioprine in dermatology: the past, the present, and the future","volume":"55","author":"Patel","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0025","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2133.2011.10575.x","article-title":"British Association of Dermatologists\u2019 guidelines for the safe and effective prescribing of azathioprine 2011","volume":"165","author":"Meggitt","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1067\/mjd.2000.103980","article-title":"Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case","volume":"42","author":"Tavadia","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0035","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1365-4362.1992.tb03548.x","article-title":"Azathioprine: a forgotten alternative for treatment of severe psoriasis","volume":"31","author":"Hacker","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0040","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.jaad.2010.06.017","article-title":"Cutaneous lupus erythematosus: update of therapeutic options part II","volume":"65","author":"Kuhn","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.det.2011.06.009","article-title":"Azathioprine in the treatment of autoimmune blistering diseases","volume":"29","author":"Meyer","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2020.05.003_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2013.09.010","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy","volume":"70","author":"Murase","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0055","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/gast.2001.28692","article-title":"Azathioprine treatment and male fertility in inflammatory bowel disease","volume":"121","author":"Dejaco","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.abd.2020.05.003_bib0060","first-page":"834","article-title":"Systemic lupus erythematosus in pregnancy treated with azathioprine","volume":"59","author":"Gillibrand","year":"1966","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.abd.2020.05.003_bib0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7326\/0003-4819-82-1-113","article-title":"Pregnancy after renal transplantation","volume":"82","author":"Tagatz","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.abd.2020.05.003_bib0070","doi-asserted-by":"crossref","first-page":"101509","DOI":"10.1016\/j.berh.2020.101509","article-title":"Opportunistic tropical infections in immunosuppressed patients","author":"Shu Kurizky","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0075","article-title":"Pregnancy outcome following in utero exposure to azathioprine: a French comparative observational study","author":"Alami","year":"2017","journal-title":"Therapie"},{"key":"10.1016\/j.abd.2020.05.003_bib0080","first-page":"341","article-title":"Connective tissue disorders and pregnancy. Recommendations for prescribing","volume":"43","author":"Rayburn","year":"1998","journal-title":"J Reprod Med"},{"key":"10.1016\/j.abd.2020.05.003_bib0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.crohns.2010.10.005","article-title":"Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding","volume":"5","author":"Angelberger","year":"2011","journal-title":"J Crogns Colitis"},{"key":"10.1016\/j.abd.2020.05.003_bib0090","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/CCID.S75908","article-title":"Management of pemphigus vulgaris: challenges and solutions","volume":"8","author":"Gregoriou","year":"2015","journal-title":"Clin Cosmet Investg Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0095","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4103\/0019-5154.185710","article-title":"A comparative effectiveness research of azathioprine and cyclophosphamide on the clinical and serological response in pemphigus vulgaris","volume":"61","author":"Sardana","year":"2016","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0100","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s12325-016-0343-4","article-title":"Management of pemphigus vulgaris","volume":"33","author":"Cholera","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.abd.2020.05.003_bib0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.aller.2010.12.009","article-title":"Efficacy and safety of azathioprine and dapsone as an adjuvant in the treatment of bullous pemphigoid","volume":"40","author":"Tirado-Sanchez","year":"2012","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.abd.2020.05.003_bib0110","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0115","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/0378-6323.82398","article-title":"Bullous pemphigoid","volume":"77","author":"Khandpur","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.abd.2020.05.003_bib0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/11315930-000000000-00000","article-title":"Diagnosis and pharmacological treatment of chronic actinic dermatitis in the elderly: an update","volume":"27","author":"Forsyth","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.abd.2020.05.003_bib0125","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4103\/0019-5154.160480","article-title":"Prolonged remission of psoriasis with azathioprine pulse therapy","volume":"60","author":"Gupta","year":"2015","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1468-3083.2008.03039.x","article-title":"Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort","volume":"23","author":"Dalaker","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.05.003_bib0135","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.abd.2020.05.003_bib0140","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40265-014-0219-3","article-title":"Advances in the diagnosis and therapeutic management of atopic dermatitis","volume":"74","author":"Vestergaard","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.abd.2020.05.003_bib0145","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(06)68340-2","article-title":"Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomized controlled trial","volume":"367","author":"Meggitt","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.abd.2020.05.003_bib0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12969-016-0100-x","article-title":"Azathioprine therapy for steroid-resistant Henoch-Sch\u00f6nlein purpura: a report of 6 cases","volume":"14","author":"Fotis","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.abd.2020.05.003_bib0155","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomized trial","volume":"74","author":"Jones","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.abd.2020.05.003_bib0160","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaad.2015.05.025","article-title":"Azathioprine treatment of intractable pruritus: a retrospective review","volume":"73","author":"Maley","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0165","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1365-2036.2008.03843.x","article-title":"Azathioprine treatment during lactation","volume":"28","author":"Christensen","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.abd.2020.05.003_bib0170","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.det.2010.03.007","article-title":"Innovative management of lupus erythematosus","volume":"28","author":"Knott","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2020.05.003_bib0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/joim.12511","article-title":"Update on the pharmacological treatment of adult myositis","volume":"280","author":"Oddis","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.abd.2020.05.003_bib0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ddg.12909","article-title":"Guidelines on dermatomyositis \u2013 excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology","volume":"14","author":"Sunderkotter","year":"2016","journal-title":"J Stscg Dermatol Ges"},{"key":"10.1016\/j.abd.2020.05.003_bib0185","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1365-4632.2010.04576.x","article-title":"Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata?. A pilot study","volume":"49","author":"Farshi","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0190","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jaad.2015.12.055","article-title":"Treatment of recalcitrant adult alopecia areata universalis with oral azathioprine","volume":"74","author":"Vano-Galvan","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0195","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1365-4632.2012.05741.x","article-title":"Eosinophilic fasciitis\/generalized morphea overlap successfully treated with azathioprine","volume":"53","author":"Alonso-Castro","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0200","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00128071-200405060-00003","article-title":"Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents","volume":"5","author":"Baughman","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0190-9622(98)70414-1","article-title":"Psoriasis and bullous pemphigoid treated with azathioprine","volume":"39","author":"Primka","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0210","first-page":"537","article-title":"Psoriatic erythroderma and bullous pemphigoid treated successfully with acitretin and azathioprine","volume":"9","author":"Roeder","year":"1999","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0215","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jaad.2010.04.041","article-title":"The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome","volume":"65","author":"Bidinger","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.003_bib0220","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16515","article-title":"Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice","author":"Gisondi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059620302191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059620302191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:38:53Z","timestamp":1759793933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059620302191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0365059620302191"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2020.05.003","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azathioprine: its uses in dermatology","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2020.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}